Transgender women continue to face the risk of developing prostate cancer. A recent study conducted by Cedars-Sinai Cancer researchers, published in...

WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of...

A research effort led by Dean Tang, PhD, of Roswell Park Comprehensive Cancer Center, USA, sheds light on a critical area of oncologic study — the...

Researchers from the Institut d’Investigació en Atenció Primària Jordi Gol (IDIAPJGol) and the Barcelona Institute for Global Health (ISGlobal),...

FRIDAY, June 28, 2024 -- Precision-guided treatment improves outcomes for children with high-risk cancer, according to a study published online June...

A groundbreaking study from the University of Texas MD Anderson Cancer Center, USA, reveals significant insights into the long-term outcomes for women...

Modern therapies have extended the lives of many cancer patients; however, survivors often live with chronic health conditions, including...

A genetic variation common in people of African ancestry is associated with an increased risk of complications from diabetes, including diabetic...

Study finds that transgender women on hormone therapy may have early-stage prostate cancer missed by current PSA screening guidelines.

A recent study published in the Journal of the American Medical Association (JAMA) has shed new light on prostate-specific antigen (PSA) values among...